BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23518145)

  • 1. The use of DWI to assess spleen and liver quantitative ADC changes in the detection of liver fibrosis stages in chronic viral hepatitis.
    Cece H; Ercan A; Yıldız S; Karakas E; Karakas O; Boyacı FN; Aydogan T; Karakas EY; Cullu N; Ulas T
    Eur J Radiol; 2013 Aug; 82(8):e307-12. PubMed ID: 23518145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of liver and spleen ADC measurements in the diagnosis and follow up of hepatic fibrosis in chronic liver disease.
    Tokgöz Ö; Unal I; Turgut GG; Yildiz S
    Acta Clin Belg; 2014 Dec; 69(6):426-32. PubMed ID: 25103596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ.
    Do RK; Chandarana H; Felker E; Hajdu CH; Babb JS; Kim D; Taouli B
    AJR Am J Roentgenol; 2010 Sep; 195(3):671-6. PubMed ID: 20729445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative ADC measurement for liver fibrosis diagnosis in chronic hepatitis B using spleen/renal cortex as the reference organs at 3 T.
    Hong Y; Shi Y; Liao W; Klahr NJ; Xia F; Xu C; Li Y; Guo Q
    Clin Radiol; 2014 Jun; 69(6):581-8. PubMed ID: 24581967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted imaging (DWI) of the spleen in patients with liver cirrhosis and portal hypertension.
    Klasen J; Lanzman RS; Wittsack HJ; Kircheis G; Schek J; Quentin M; Antoch G; Häussinger D; Blondin D
    Magn Reson Imaging; 2013 Sep; 31(7):1092-6. PubMed ID: 23731536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis.
    Sandrasegaran K; Akisik FM; Lin C; Tahir B; Rajan J; Saxena R; Aisen AM
    AJR Am J Roentgenol; 2009 Dec; 193(6):1556-60. PubMed ID: 19933647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver fibrosis: evaluation with diffusion-weighted magnetic resonance imaging in patients with chronic liver disease.
    Catanzaro R; Sapienza C; Milazzo M; Arona S; Italia A; Samperi L
    Minerva Gastroenterol Dietol; 2013 Sep; 59(3):313-20. PubMed ID: 23867950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience.
    Taouli B; Tolia AJ; Losada M; Babb JS; Chan ES; Bannan MA; Tobias H
    AJR Am J Roentgenol; 2007 Oct; 189(4):799-806. PubMed ID: 17885048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study on clinical and pathological changes of liver fibrosis with diffusion-weighted imaging].
    Zhou ML; Yan FH; Xu PJ; Chen CZ; Shen JZ; Li RC; Ji Y; Shi JY
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(25):1757-61. PubMed ID: 19862980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between two-point and four-point methods for quantification of apparent diffusion coefficient of normal liver parenchyma and focal lesions. Value of normalization with spleen.
    Papanikolaou N; Gourtsoyianni S; Yarmenitis S; Maris T; Gourtsoyiannis N
    Eur J Radiol; 2010 Feb; 73(2):305-9. PubMed ID: 19091503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted MR imaging of the liver of hepatitis C patients.
    Boulanger Y; Amara M; Lepanto L; Beaudoin G; Nguyen BN; Allaire G; Poliquin M; Nicolet V
    NMR Biomed; 2003 May; 16(3):132-6. PubMed ID: 12884356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field strength and diffusion encoding technique affect the apparent diffusion coefficient measurements in diffusion-weighted imaging of the abdomen.
    Dale BM; Braithwaite AC; Boll DT; Merkle EM
    Invest Radiol; 2010 Feb; 45(2):104-8. PubMed ID: 20027117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade.
    Fujimoto K; Tonan T; Azuma S; Kage M; Nakashima O; Johkoh T; Hayabuchi N; Okuda K; Kawaguchi T; Sata M; Qayyum A
    Radiology; 2011 Mar; 258(3):739-48. PubMed ID: 21248235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial study of biexponential model of intravoxel incoherent motion magnetic resonance imaging in evaluation of the liver fibrosis.
    Chen C; Wang B; Shi D; Fu F; Zhang J; Wen Z; Zhu S; Xu J; Lin Q; Li J; Dou S
    Chin Med J (Engl); 2014; 127(17):3082-7. PubMed ID: 25189949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-source parallel RF transmission for diffusion-weighted imaging of the abdomen using different b values: image quality and apparent diffusion coefficient comparison with conventional single-source transmission.
    Guo L; Liu C; Chen W; Chan Q; Wang G
    J Magn Reson Imaging; 2013 Apr; 37(4):875-85. PubMed ID: 23097254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of conventional diffusion weighted imaging and diffusion tensor imaging for the liver fibrosis and inflammation.
    Tosun M; Inan N; Sarisoy HT; Akansel G; Gumustas S; Gürbüz Y; Demirci A
    Eur J Radiol; 2013 Feb; 82(2):203-7. PubMed ID: 23122674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C.
    Lewin M; Poujol-Robert A; Boëlle PY; Wendum D; Lasnier E; Viallon M; Guéchot J; Hoeffel C; Arrivé L; Tubiana JM; Poupon R
    Hepatology; 2007 Sep; 46(3):658-65. PubMed ID: 17663420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.
    Keller S; Sedlacik J; Schuler T; Buchert R; Avanesov M; Zenouzi R; Lohse AW; Kooijman H; Fiehler J; Schramm C; Yamamura J
    Eur Radiol; 2019 Feb; 29(2):818-828. PubMed ID: 30014204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
    Benndorf M; Schelhorn J; Dietzel M; Kaiser WA; Baltzer PA
    Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of diffusion-weighted magnetic resonance imaging in the classification of hepatic hydatid cysts.
    Ceçe H; Gündoğan M; Karakaş O; Karakaş E; Boyacı FN; Yıldız S; Ozgönül A; Karakaş EY; Cullu N; Seker A
    Eur J Radiol; 2013 Jan; 82(1):90-4. PubMed ID: 23177089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.